E Dammann
Overview
Explore the profile of E Dammann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weissinger E, Metzger J, Dobbelstein C, Wolff D, Schleuning M, Kuzmina Z, et al.
Leukemia
. 2013 Jul;
28(4):842-52.
PMID: 23842427
Allogeneic hematopoietic stem cell transplantation is one curative treatment for hematological malignancies, but is compromised by life-threatening complications, such as severe acute graft-versus-host disease (aGvHD). Prediction of severe aGvHD as...
2.
Borchers S, Weissinger E, Pabst B, Ganzenmueller T, Dammann E, Luther S, et al.
Transpl Infect Dis
. 2013 Jun;
15(6):627-33.
PMID: 23782397
Donor chimerism (DC) analysis is an important marker in the hematopoietic stem cell transplant follow-up. Here, we present evidence for a possible relationship of infectious complications and declines in DC....
3.
Koenecke C, Hertenstein B, Schetelig J, van Biezen A, Dammann E, Gratwohl A, et al.
Am J Transplant
. 2010 Jul;
10(8):1897-906.
PMID: 20659095
To analyze the outcome of solid organ transplantation (SOT) in patients who had undergone allogeneic hematopoietic stem cell transplantation (HSCT), a questionnaire survey was carried out within 107 European Group...
4.
Krauter J, Wagner K, Stadler M, Dammann E, Zucknick M, Eder M, et al.
Bone Marrow Transplant
. 2010 Jun;
46(4):545-51.
PMID: 20548341
The prognosis of elderly patients with AML after chemotherapy is poor. Allo-SCT is feasible in these patients, but data on prognostic factors and outcome are limited. We analyzed all 102...
5.
Buchholz S, Dammann E, Koenecke C, Stadler M, Franzke A, Blasczyk R, et al.
Ann Hematol
. 2008 Apr;
87(7):551-6.
PMID: 18386010
Aplastic anaemia (AA) is a rare bone marrow failure syndrome treated either by immunosuppressive therapy or allogeneic stem cell transplantation (SCT). At present, no randomised clinical trials evaluating both treatment...
6.
Baumer T, Dammann E, Bock F, Kloppel S, Siebner H, Munchau A
Exp Brain Res
. 2007 Feb;
180(2):195-203.
PMID: 17287992
There is some evidence that handedness is related to lateralisation of excitability in the motor system. We investigated lateralisation of interhemispheric inhibition (IHI), motor thresholds and short interval intracortical inhibition...
7.
Weissinger E, Oettrich K, Evans C, Genieser H, Schwede F, Dangers M, et al.
Br J Cancer
. 2004 Jun;
91(1):186-92.
PMID: 15188002
Activation of PKA by cAMP agonists, such as 8-Cl-cAMP activation, selectively causes rapid apoptosis in v-abl transformed fibroblasts by inhibiting the Raf-1 kinase. Here we investigated whether 8-Cl-cAMP is useful...
8.
Hambach L, Stadler M, Dammann E, Ganser A, Hertenstein B
Bone Marrow Transplant
. 2002 Jun;
29(11):903-6.
PMID: 12080355
Mycophenolate mofetil (MMF) is increasingly used for prophylaxis and therapy of GVHD in allogeneic stem cell transplantation. In some recent reports of use of MMF in solid organ transplantation a...
9.
Hambach L, Eder M, Dammann E, Battmer K, Stucki A, Heil G, et al.
Bone Marrow Transplant
. 2001 Nov;
28(7):705-7.
PMID: 11704795
We report a patient with Ph-positive CML who developed a Ph-negative AML in donor cells 14 months after BMT from an HLA-identical male unrelated donor. The Ph translocation could not...
10.
Shlapentokh V, Dammann E, Drury A
J Health Soc Policy
. 1993 Dec;
6(2):19-34.
PMID: 10141129
No abstract available.